These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 38272903)

  • 1. Author Correction: Proof of concept for a single-dose Group B Streptococcus vaccine based on capsular polysaccharide conjugated to Qβ virus-like particles.
    Carboni F; Cozzi R; Romagnoli G; Tuscano G; Balocchi C; Buffi G; Bodini M; Brettoni C; Giusti F; Marchi S; Brogioni G; Brogioni B; Cinelli P; Cappelli L; Nocciolini C; Senesi S; Facciotti C; Frigimelica E; Fabbrini M; Stranges D; Savino S; Maione D; Adamo R; Wizel B; Margarit I; Romano MR
    NPJ Vaccines; 2024 Jan; 9(1):19. PubMed ID: 38272903
    [No Abstract]   [Full Text] [Related]  

  • 2. Proof of concept for a single-dose Group B Streptococcus vaccine based on capsular polysaccharide conjugated to Qβ virus-like particles.
    Carboni F; Cozzi R; Romagnoli G; Tuscano G; Balocchi C; Buffi G; Bodini M; Brettoni C; Giusti F; Marchi S; Brogioni G; Brogioni B; Cinelli P; Cappelli L; Nocciolini C; Senesi S; Facciotti C; Frigimelica E; Fabbrini M; Stranges D; Savino S; Maione D; Adamo R; Wizel B; Margarit I; Romano MR
    NPJ Vaccines; 2023 Oct; 8(1):152. PubMed ID: 37803013
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Group B Streptococcus chimeric capsular polysaccharides as novel multivalent vaccine candidates.
    Campisi E; Rosini R; Romano MR; Balducci E; Pinto V; Brogioni B; De Ricco R; Fabbrini M; Spagnuolo A; Chiarot E; Berti F; Margarit I
    Glycoconj J; 2021 Aug; 38(4):447-457. PubMed ID: 33956253
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bacteriophage Qβ virus-like particles displaying Chikungunya virus B-cell epitopes elicit high-titer E2 protein antibodies but fail to neutralize a Thailand strain of Chikungunya virus.
    Basu R; Zhai L; Rosso B; Tumban E
    Vaccine; 2020 Mar; 38(11):2542-2550. PubMed ID: 32044164
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Virus-like Particle Display of
    Rashidijahanabad Z; Kelly M; Kamruzzaman M; Qadri F; Bhuiyan TR; McFall-Boegeman H; Wu D; Piszczek G; Xu P; Ryan ET; Huang X
    ACS Infect Dis; 2022 Mar; 8(3):574-583. PubMed ID: 35170309
    [No Abstract]   [Full Text] [Related]  

  • 6. Der p 1 peptide on virus-like particles is safe and highly immunogenic in healthy adults.
    Kündig TM; Senti G; Schnetzler G; Wolf C; Prinz Vavricka BM; Fulurija A; Hennecke F; Sladko K; Jennings GT; Bachmann MF
    J Allergy Clin Immunol; 2006 Jun; 117(6):1470-6. PubMed ID: 16751015
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Melt Processing Virus-Like Particle-Based Vaccine Candidates into Biodegradable Polymer Implants.
    Puente AA; Ortega-Rivera OA; Wirth DM; Pokorski JK; Steinmetz NF
    Methods Mol Biol; 2024; 2720():221-245. PubMed ID: 37775669
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exploring the Group B Streptococcus capsular polysaccharides: the structural diversity provides the basis for development of NMR-based identity assays.
    Pinto V; Berti F
    J Pharm Biomed Anal; 2014 Sep; 98():9-15. PubMed ID: 24873733
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of the linkage between the type III capsular polysaccharide and the bacterial cell wall of group B Streptococcus.
    Deng L; Kasper DL; Krick TP; Wessels MR
    J Biol Chem; 2000 Mar; 275(11):7497-504. PubMed ID: 10713053
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Scalable Manufacturing Approach to Single Dose Vaccination against HPV.
    Shao S; A Ortega-Rivera O; Ray S; K Pokorski J; F Steinmetz N
    Vaccines (Basel); 2021 Jan; 9(1):. PubMed ID: 33478147
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elicitation of integrated immunity in mice by a novel pneumococcal polysaccharide vaccine conjugated with HBV surface antigen.
    Qian W; Huang Z; Chen Y; Yang J; Wang L; Wu K; Chen M; Chen N; Duan Y; Shi J; Zhang Y; Li Q
    Sci Rep; 2020 Apr; 10(1):6470. PubMed ID: 32286332
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Head-to-Head Comparison of Soluble vs. Qβ VLP Circumsporozoite Protein Vaccines Reveals Selective Enhancement of NANP Repeat Responses.
    Khan F; Porter M; Schwenk R; DeBot M; Saudan P; Dutta S
    PLoS One; 2015; 10(11):e0142035. PubMed ID: 26571021
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Novel Hexavalent Capsular Polysaccharide Conjugate Vaccine (GBS6) for the Prevention of Neonatal Group B Streptococcal Infections by Maternal Immunization.
    Buurman ET; Timofeyeva Y; Gu J; Kim JH; Kodali S; Liu Y; Mininni T; Moghazeh S; Pavliakova D; Singer C; Singh S; Handke LD; Lotvin J; Prasad AK; Scully IL; Donald RGK; Jansen KU; Anderson AS
    J Infect Dis; 2019 Jun; 220(1):105-115. PubMed ID: 30778554
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protection against Streptococcus suis Serotype 2 Infection Using a Capsular Polysaccharide Glycoconjugate Vaccine.
    Goyette-Desjardins G; Calzas C; Shiao TC; Neubauer A; Kempker J; Roy R; Gottschalk M; Segura M
    Infect Immun; 2016 Jul; 84(7):2059-2075. PubMed ID: 27113360
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential idiotype utilization for the in vivo type 14 capsular polysaccharide-specific Ig responses to intact Streptococcus pneumoniae versus a pneumococcal conjugate vaccine.
    Colino J; Duke L; Arjunaraja S; Chen Q; Liu L; Lucas AH; Snapper CM
    J Immunol; 2012 Jul; 189(2):575-86. PubMed ID: 22706079
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coupling Peptide Antigens to Virus-Like Particles or to Protein Carriers Influences the Th1/Th2 Polarity of the Resulting Immune Response.
    Pomwised R; Intamaso U; Teintze M; Young M; Pincus SH
    Vaccines (Basel); 2016 May; 4(2):. PubMed ID: 27164150
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Group B Streptococcus type II polysaccharide-tetanus toxoid conjugate vaccine.
    Paoletti LC; Wessels MR; Michon F; DiFabio J; Jennings HJ; Kasper DL
    Infect Immun; 1992 Oct; 60(10):4009-14. PubMed ID: 1398913
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunogenicity in animals of a polysaccharide-protein conjugate vaccine against type III group B Streptococcus.
    Wessels MR; Paoletti LC; Kasper DL; DiFabio JL; Michon F; Holme K; Jennings HJ
    J Clin Invest; 1990 Nov; 86(5):1428-33. PubMed ID: 2243123
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure of the type IX group B Streptococcus capsular polysaccharide and its evolutionary relationship with types V and VII.
    Berti F; Campisi E; Toniolo C; Morelli L; Crotti S; Rosini R; Romano MR; Pinto V; Brogioni B; Torricelli G; Janulczyk R; Grandi G; Margarit I
    J Biol Chem; 2014 Aug; 289(34):23437-48. PubMed ID: 24990951
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relevance of O-acetyl and phosphoglycerol groups for the antigenicity of Streptococcus pneumoniae serotype 18C capsular polysaccharide.
    Chang J; Serrano Y; Garrido R; Rodríguez LM; Pedroso J; Cardoso F; Valdés Y; García D; Fernández-Santana V; Verez-Bencomo V
    Vaccine; 2012 Nov; 30(49):7090-6. PubMed ID: 23036500
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.